Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Low-level laser therapy ameliorates disease progression in a mouse model of multiple sclerosis.
LSN MS guidelines for the management of multiple sclerosis.
Tongue Somatosensory-Evoked Potentials: Evaluation of the Afferent Trigeminal Pathway in Patients With Early Multiple Sclerosis.
[Clinical features of neuromyelitis optica and the distribution of Chinese medical syndrome types: a case report of 63 cases].
The relationship between total and regional corpus callosum atrophy, cognitive impairment and fatigue in multiple sclerosis patients.
Outcome Measures for Individuals With Multiple Sclerosis: Recommendations From the American Physical Therapy Association Neurology Section Task Force.
The complement cascade: Yin-Yang in neuroinflammation--neuro-protection and -degeneration.
Bidirectional trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis.
Mapping the accumulation of co-infiltrating CNS dendritic cells and encephalitogenic T cells during EAE.
Multiple sclerosis: managing a complex neurological disease.
Chromatin Landscape Defined by Repressive Histone Methylation during Oligodendrocyte Differentiation.
Identification of suitable reference genes for peripheral blood mononuclear cell subset studies in multiple sclerosis.
Multiple sclerosis in 2012: Novel therapeutic options and drug targets in MS.
Diffusion tensor imaging in the human spinal cord: development, limitations, and clinical applications.
Investigation of heterogeneity in the association between interferon beta and disability progression in multiple sclerosis: an observational study.
Circadian rhythmicity of inflammatory serum parameters: a neglected issue in the search of biomarkers in multiple sclerosis.
Progressive multiple sclerosis exhibits decreasing glutamate and glutamine over two years.
TNF-alpha Production by Peripheral Blood Monocytes in Multiple Sclerosis Patients and Healthy Controls.
XY sex chromosome complement, compared with XX, in the CNS confers greater neurodegeneration during experimental autoimmune encephalomyelitis
Higher burden of migraine compared to other neurological conditions: results from a cross-sectional study.
Responsibilities of Health Care Professionals in Counseling and Educating Patients With Incurable Neurological Diseases Regarding "Stem Cell Tourism": Caveat Emptor.
Building an RNA Sequencing Transcriptome of the Central Nervous System.
The multiple sclerosis depression rating scale.
CD226 Gly307Ser association with multiple autoimmune diseases: A meta-analysis.
Systemic treatment with the inhibitory neurotransmitter gamma-aminobutyric acid aggravates experimental autoimmune encephalomyelitis by affecting proinflammatory immune responses.
Pages
« first
‹ previous
…
298
299
300
301
302
303
304
305
306
…
next ›
last »